InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,443.20
(
2.15%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
-1.03%
)
Bitcoin
63,124.07
(
6.77%
)
Post# of 285861
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

SSP

Send PM Follow Ignore
Followers 642
Posts 44671
Boards Moderated 3
Alias Born 08/02/2000

SSP

Member Level

Re: CPTMatt post# 254400

Tuesday, 08/19/2014 9:34:02 AM

Tuesday, August 19, 2014 9:34:02 AM

Post# of 285861
NBY - “We also recently reported that enrollment in our BAYnovation clinical trial for viral conjunctivitis has been completed and we are in the process of accumulating the data from U.S. and international sites. We anticipate reporting top-line results mid-August,” concluded Dr. Najafi.

http://novabay.com/pressrelease/novabay-pharmaceuticals-reports-second-quarter-2014-financial-results-clinicalbusiness-update
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up